Seeger, Markus
Stylogiannis, Antonios
Prade, Ludwig
Glasl, Sarah
Ntziachristos, Vasilis
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (CRC 1123 (Z1))
Bundesministerium für Bildung und Forschung (13N13855 (Sense4Life))
Horizon 2020 Framework Programme (No 862811 (RSENSE))
Technische Universität München
Article History
Received: 12 July 2023
Accepted: 6 November 2023
First Online: 9 November 2023
Competing interests
: Vasilis Ntziachristos is a founder and equity owner of sThesis GmbH, iThera Medical GmbH, Spear UG, and i3 Inc. The remaining authors have no competing interests.